BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 28342726)

  • 1. Noninvasive prenatal testing for fetal aneuploidy and single gene disorders.
    Skrzypek H; Hui L
    Best Pract Res Clin Obstet Gynaecol; 2017 Jul; 42():26-38. PubMed ID: 28342726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal Plasma DNA and RNA Sequencing for Prenatal Testing.
    Tamminga S; van Maarle M; Henneman L; Oudejans CB; Cornel MC; Sistermans EA
    Adv Clin Chem; 2016; 74():63-102. PubMed ID: 27117661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antenatal noninvasive DNA testing: clinical experience and impact.
    Ferres MA; Hui L; Bianchi DW
    Am J Perinatol; 2014 Aug; 31(7):577-82. PubMed ID: 24683075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of cell-free fetal DNA in maternal plasma for noninvasive prenatal screening.
    Wagner AJ; Mitchell ME; Tomita-Mitchell A
    Clin Perinatol; 2014 Dec; 41(4):957-66. PubMed ID: 25459783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noninvasive Detection of Fetal Aneuploidy Using Next Generation Sequencing.
    Curnow KJ; Sanderson RK; Beruti S
    Methods Mol Biol; 2019; 1885():325-345. PubMed ID: 30506208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-Free DNA Screening for Aneuploidy and Microdeletion Syndromes.
    Shaffer BL; Norton ME
    Obstet Gynecol Clin North Am; 2018 Mar; 45(1):13-26. PubMed ID: 29428281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective observations study protocol to investigate cost-effectiveness of various prenatal test strategies after the introduction of noninvasive prenatal testing.
    Kim SY; Lee SM; Jun JK; Han YJ; Kim MH; Shim JY; Lee MY; Oh SY; Lee J; Kim SH; Cha DH; Cho GJ; Kwon HS; Kim BJ; Park MH; Cho HY; Ko HS; Ahn J; Ryu HM
    BMC Pregnancy Childbirth; 2018 Jul; 18(1):307. PubMed ID: 30041617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Forward Look At Noninvasive Prenatal Testing.
    Liu L; Li K; Fu X; Chung C; Zhang K
    Trends Mol Med; 2016 Nov; 22(11):958-968. PubMed ID: 27726956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive prenatal testing using cell-free fetal DNA in maternal plasma.
    Dharajiya N; Zwiefelhofer T; Guan X; Angkachatchai V; Saldivar JS
    Curr Protoc Hum Genet; 2015 Jan; 84():8.15.1-8.15.20. PubMed ID: 25599670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex chromosome aneuploidy detection by noninvasive prenatal testing: helpful or hazardous?
    Reiss RE; Discenza M; Foster J; Dobson L; Wilkins-Haug L
    Prenat Diagn; 2017 May; 37(5):515-520. PubMed ID: 28326560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A two-year experience of non-invasive prenatal testing (NIPT) at an urban tertiary medical center in South Korea.
    Noh JJ; Ryu HM; Oh SY; Choi SJ; Roh CR; Kim JH
    Taiwan J Obstet Gynecol; 2019 Jul; 58(4):545-551. PubMed ID: 31307749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-free DNA noninvasive prenatal screening for aneuploidy versus conventional screening: A systematic review of economic evaluations.
    Nshimyumukiza L; Menon S; Hina H; Rousseau F; Reinharz D
    Clin Genet; 2018 Jul; 94(1):3-21. PubMed ID: 29030960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing use of existing prenatal genetic tests: Screening and diagnostic testing for aneuploidy.
    Stoll K; Norton ME
    Semin Perinatol; 2018 Aug; 42(5):296-302. PubMed ID: 30209012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Have we done our last amniocentesis? Updates on cell-free DNA for Down syndrome screening.
    Gray KJ; Wilkins-Haug LE
    Pediatr Radiol; 2018 Apr; 48(4):461-470. PubMed ID: 29550862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modifying Risk of Aneuploidy with a Positive Cell-Free Fetal DNA Result.
    Long AA; Abuhamad AZ; Warsof SL
    Clin Lab Med; 2016 Jun; 36(2):249-59. PubMed ID: 27235910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pilot study of a novel multi-functional noninvasive prenatal test on fetus aneuploidy, copy number variation, and single-gene disorder screening.
    Luo Y; Jia B; Yan K; Liu S; Song X; Chen M; Jin F; Du Y; Wang J; Hong Y; Cao S; Li D; Dong M
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00597. PubMed ID: 30767419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive Prenatal Testing and Incidental Detection of Occult Maternal Malignancies.
    Bianchi DW; Chudova D; Sehnert AJ; Bhatt S; Murray K; Prosen TL; Garber JE; Wilkins-Haug L; Vora NL; Warsof S; Goldberg J; Ziainia T; Halks-Miller M
    JAMA; 2015 Jul; 314(2):162-9. PubMed ID: 26168314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive prenatal detection of aneuploidy.
    Robinson C; van den Boom D; Bombard AT
    Clin Obstet Gynecol; 2014 Mar; 57(1):210-25. PubMed ID: 24351443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine.
    Friel LA; Czerwinski JL; Singletary CN
    Am J Perinatol; 2014 Oct; 31(9):759-64. PubMed ID: 24338115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.